Catalyst Pharmaceuticals (CPRX) Non-Current Deffered Revenue (2011 - 2013)

Catalyst Pharmaceuticals has reported Non-Current Deffered Revenue for 3 years, with the latest figure at $19131.0 in Q4 2013.

• For the quarter ending Q4 2013, Non-Current Deffered Revenue fell 12.56% year-over-year to $19131.0; the trailing twelve-month figure through Dec 2013 stood at $19131.0 (down 12.56% YoY), and the FY2013 full-year result was $19131.0, down 12.56% from the prior year.
• Non-Current Deffered Revenue for Q4 2013 stood at $19131.0, down from $20040.0 in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $22004.0 in Q2 2012, with the low at $9518.0 in Q4 2011.
• Historically, Non-Current Deffered Revenue has averaged $19212.7 across 3 years, with a median of $20653.0 in 2013.
• Annual changes were most pronounced in 2012 — Non-Current Deffered Revenue jumped 129.86% — and 2013, when it slipped 12.56%.
• Catalyst Pharmaceuticals' Non-Current Deffered Revenue stood at $9518.0 in 2011, then jumped by 129.86% to $21878.0 in 2012, then declined by 12.56% to $19131.0 in 2013.
• The last three Non-Current Deffered Revenue figures came in at $19131.0 (Q4 2013), $20040.0 (Q3 2013), and $20653.0 (Q2 2013), per Business Quant data.